Dr Michael Levy has resigned as VP research and chief medical office of Glaxo Wellcome Canada. Levy, considered one of the shining stars of the Canadian pharmaceutical sector, has accepted a position with Tularik Inc, a biotechnology firm based in San Francisco CA. Levy will assume the duties of VP development and chief medical officer, leading Tularik's development activities with a focus on new drug approvals. As a member of the senior management team, he will also play a role in the company's strategic direction. The new position represents a marked change from Levy's duties at Glaxo Wellcome, which were l